NovMetaPharma Co., Ltd. (XKON:229500)
7,200.00
+400.00 (5.88%)
At close: Jul 20, 2026
-37.39% (1Y)
| Market Cap | 78.59B -43.6% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 51.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,181 |
| Open | 6,990.00 |
| Previous Close | 6,800.00 |
| Day's Range | 6,230.00 - 7,200.00 |
| 52-Week Range | 5,850.00 - 17,890.00 |
| Beta | 0.16 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |